263 related articles for article (PubMed ID: 11809769)
21. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14.
Béréziat V; Kasus-Jacobi A; Perdereau D; Cariou B; Girard J; Burnol AF
J Biol Chem; 2002 Feb; 277(7):4845-52. PubMed ID: 11726652
[TBL] [Abstract][Full Text] [Related]
23. Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration.
Jones N; Master Z; Jones J; Bouchard D; Gunji Y; Sasaki H; Daly R; Alitalo K; Dumont DJ
J Biol Chem; 1999 Oct; 274(43):30896-905. PubMed ID: 10521483
[TBL] [Abstract][Full Text] [Related]
24. Dimerization in the Grb7 protein.
Peterson TA; Benallie RL; Bradford AM; Pias SC; Yazzie J; Lor SN; Haulsee ZM; Park CK; Johnson DL; Rohrschneider LR; Spuches A; Lyons BA
J Mol Recognit; 2012 Aug; 25(8):427-34. PubMed ID: 22811067
[TBL] [Abstract][Full Text] [Related]
25. Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3.
Fiddes RJ; Campbell DH; Janes PW; Sivertsen SP; Sasaki H; Wallasch C; Daly RJ
J Biol Chem; 1998 Mar; 273(13):7717-24. PubMed ID: 9516479
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular Activity.
Sang J; Kulkarni K; Watson GM; Ma X; Craik DJ; Henriques ST; Poth AG; Benfield AH; Wilce JA
Molecules; 2019 Oct; 24(20):. PubMed ID: 31627265
[TBL] [Abstract][Full Text] [Related]
27. Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases.
Lock LS; Royal I; Naujokas MA; Park M
J Biol Chem; 2000 Oct; 275(40):31536-45. PubMed ID: 10913131
[TBL] [Abstract][Full Text] [Related]
28. Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain Target.
Watson GM; Lucas WAH; Gunzburg MJ; Wilce JA
Front Mol Biosci; 2017; 4():64. PubMed ID: 29018805
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins.
Sotgia F; Lee H; Bedford MT; Petrucci T; Sudol M; Lisanti MP
Biochemistry; 2001 Dec; 40(48):14585-92. PubMed ID: 11724572
[TBL] [Abstract][Full Text] [Related]
30. Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor.
Thömmes K; Lennartsson J; Carlberg M; Rönnstrand L
Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):211-6. PubMed ID: 10377264
[TBL] [Abstract][Full Text] [Related]
31. Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target.
Watson GM; Gunzburg MJ; Ambaye ND; Lucas WA; Traore DA; Kulkarni K; Cergol KM; Payne RJ; Panjikar S; Pero SC; Perlmutter P; Wilce MC; Wilce JA
J Med Chem; 2015 Oct; 58(19):7707-18. PubMed ID: 26359549
[TBL] [Abstract][Full Text] [Related]
32. Direct association between the Ret receptor tyrosine kinase and the Src homology 2-containing adapter protein Grb7.
Pandey A; Liu X; Dixon JE; Di Fiore PP; Dixit VM
J Biol Chem; 1996 May; 271(18):10607-10. PubMed ID: 8631863
[TBL] [Abstract][Full Text] [Related]
33. Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity.
Li P; Zhang M; Peach ML; Zhang X; Liu H; Nicklaus M; Yang D; Roller PP
Biochem Biophys Res Commun; 2003 Aug; 307(4):1038-44. PubMed ID: 12878216
[TBL] [Abstract][Full Text] [Related]
34. Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7.
Gunzburg MJ; Kulkarni K; Watson GM; Ambaye ND; Del Borgo MP; Brandt R; Pero SC; Perlmutter P; Wilce MC; Wilce JA
Sci Rep; 2016 Jun; 6():27060. PubMed ID: 27257138
[TBL] [Abstract][Full Text] [Related]
35. Adaptor signalling proteins Grb2 and Grb7 are recruited by human G6f, a novel member of the immunoglobulin superfamily encoded in the MHC.
De Vet EC; Aguado B; Campbell RD
Biochem J; 2003 Oct; 375(Pt 1):207-13. PubMed ID: 12852788
[TBL] [Abstract][Full Text] [Related]
36. Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonist.
Ambaye ND; Gunzburg MJ; Traore DA; Del Borgo MP; Perlmutter P; Wilce MC; Wilce JA
Acta Crystallogr F Struct Biol Commun; 2014 Feb; 70(Pt 2):182-6. PubMed ID: 24637751
[TBL] [Abstract][Full Text] [Related]
37. Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells.
Pero SC; Shukla GS; Armstrong AL; Peterson D; Fuller SP; Godin K; Kingsley-Richards SL; Weaver DL; Bond J; Krag DN
Int J Cancer; 2004 Oct; 111(6):951-60. PubMed ID: 15300809
[TBL] [Abstract][Full Text] [Related]
38. Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 domain.
Lung FD; Long YQ; Roller PP; King CR; Varady J; Wu XW; Wang S
J Pept Res; 2001 Jun; 57(6):447-54. PubMed ID: 11437948
[TBL] [Abstract][Full Text] [Related]
39. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
[TBL] [Abstract][Full Text] [Related]
40. Identification of a NPXY motif in growth factor receptor-bound protein 14 (Grb14) and its interaction with the phosphotyrosine-binding (PTB) domain of IRS-1.
Rajala RV; Chan MD
Biochemistry; 2005 Jun; 44(22):7929-35. PubMed ID: 15924411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]